National Cancer Institute | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not applicable	2026-09-09		NCT07067437
Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Active, not recruiting	Phase 2	2026-04-13		NCT03540420
Digital Solutions for bEtter cAre	Cancer Diagnosis	Recruiting	Not applicable	2026-02-18		NCT07416513
Prostate Cancer Awareness and Initiative for Screening in the European Union	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Enrolling by invitation	Not stated	2025-08-15		NCT06424275
Pathogenesis of Postoperative Infections and Biomarkers for Early Diagnosis of it	Digestive System Diseases, Digestive System Neoplasms, Infections, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, digestive system neoplasm, neoplasm	Recruiting	Not stated	2024-08-01		NCT06513598
Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2	2024-02-29		NCT04392505